Navigation Links
Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting
Date:5/21/2009

REDWOOD CITY, Calif., May 21 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from three studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2, 2009, at the Orange County Convention Center in Orlando, Florida. The company currently markets the widely-adopted Oncotype DX(R) breast cancer test, which is clinically validated to predict the likelihood of recurrence and chemotherapy benefit in early-stage breast cancer patients, and plans to launch a test for colon cancer in early 2010 based on positive results from the QUASAR validation study being presented at ASCO.

    Presentation details are as follows:

    Colon Cancer
        -- Saturday, May 30, 2009, 3 p.m. ET
           Abstract # 4000
           Oral presentation: "A quantitative multi-gene RT-PCR assay for
           prediction of recurrence in stage II colon cancer:  Selection of
           the genes in 4 large studies and results of the independent,
           prospectively-designed QUASAR validation study" Presenter: David
           Kerr, M.D., DSc, professor of cancer medicine at the University of
           Oxford Location: Level 2, West Hall D2

    In addition, an archived webcast of the advance presscast highlighting the
    QUASAR colon cancer validation study is available on ASCO's Web site at
    www.asco.org.

    Breast Cancer
        -- Sunday, May 31, 2009, 4:30 p.m. ET
           Abstract # 500
           Oral presentation: "Genotypic characterization of phenotypically
           defined triple-negative breast cancer"
           Presenter: Joseph A. Sparano, M.D., professor of medicine and
           women's health at Albert Einstein College of Medicine and director
           of the Breast Evaluation Center of Montefiore-Ei
'/>"/>
SOURCE Genomic Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... risk from thiazolidinedione use, study indicates , MONDAY, Feb. ... as thiazolidinediones, which include Avandia and Actos, are at a ... Women who took a thiazolidinedione drug for a year were ... patients who didn,t take the drug, the researchers found. Women ...
... ... Preserve Liquidity -, , QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ ... cancer diagnostic tests and delivering laboratory services, today announced changes to ... will be comprised of two business segments: (1) administrative headquarters in ...
... ... electrical stimulation device to their training regimen. , ... San Diego, CA (PRWEB) February 17, 2010 -- ... Team presented by Kenda– a US Continental pro men’s cycling team which competes at ...
... ... turnarounds and improving hospital profitability joins StatCom in a strategic partnership program that helps hospitals ... ... Tom Brunelle FACHE, MBA, to the StatCom team. Previously Brunelle served as EVP and CEO ...
... Facelift surgery, ... is becoming more popular than ever in the battle to slow the progression of facial ... , ... February 15, 2010 – Facelift surgery is the second most popular cosmetic surgical ...
... , SALT LAKE CITY , ... (AAPC) announced its 2010 National Conference being held at the Gaylord Opryland ... event draws thousands of attendees including doctors, medical coders and office/practice managers ... the first time this conference has been approved for 15.75 (CME) ...
Cached Medicine News:Health News:Diabetes Drugs Avandia, Actos Tied to Fractures in Women 2Health News:DiagnoCure announces optimization of entreprise structure 2Health News:DiagnoCure announces optimization of entreprise structure 3Health News:DiagnoCure announces optimization of entreprise structure 4Health News:Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda 2Health News:Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda 3Health News:Tom Brunelle Joins StatCom as Enterprise VP, Northeast Region 2Health News:Tom Brunelle Joins StatCom as Enterprise VP, Northeast Region 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 2Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 4Health News:AAPC to Host 18th Annual National Conference in Nashville 2Health News:AAPC to Host 18th Annual National Conference in Nashville 3
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... , ... a new market research report is available in its ... Market Review , http://www.reportlinker.com/p0164247/Insulin-Pumps-External---A-World-Market-Review.html , Insulin ... better control over diabetes, when compared to other forms ...
... , BELLEVUE, Wash., Dec. 1 ... retailer of health, beauty, vision, and pharmacy products, today announced ... orders were the highest in company history. This holiday season ... featured more special offers than in previous years and their ...
Cached Medicine Technology:Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3
9 mm diameter pigtail curved blunt probes. Stainless steel. Round knurled handle with polished finish. Includes pre-cut polyethylene tubes. Overall length: 5.9 inches....
Yag Laser System SYL is compact and light-weight. It is CE Mark approved according to MDD....
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with thumb catch lock and dull finish....
... evaluation has a choice of 4 ... automatic creation 'horse-shoe' diagrams, automatic color ... calculation of color confusion index (CCI), ... (OD, OS, OU) and test or ...
Medicine Products: